Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

Схожие документы

• Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
  по: Concordet, Didier, et al.
  Опубликовано: (2019)
• Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
  по: Concordet, Didier, et al.
  Опубликовано: (2019)
• Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
  по: Concordet, Didier, et al.
  Опубликовано: (2019)
• Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
  по: Concordet, Didier, et al.
  Опубликовано: (2019)
• Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
  по: Concordet, Didier, et al.
  Опубликовано: (2019)